Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

The present invention relates to methods of treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment a composition comprising an interleukin-13 (IL-13) antibody or an antigen-binding fragmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GULATI SHILPA, PIETSCH ROBERT, TIMONY, G, RARD
Format: Patent
Sprache:chi ; eng
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to methods of treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment a composition comprising an interleukin-13 (IL-13) antibody or an antigen-binding fragment thereof. 本发明涉及通过给需要这种治疗的主体施用含有白介素-13(IL-13)抗体或其抗原结合片段的组合物来治疗IL-13活性在其中有害的疾病（包括嗜酸性粒细胞性食管炎(EoE)和哮喘）的方法。